A Multicenter, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of Levofloxacin 750 mg Once Daily for 5 Days Versus Levofloxacin 500 mg Once Daily for 10 Days in the Treatment of Acute Bacterial Sinusitis in Adults.
Phase of Trial: Phase III
Latest Information Update: 26 May 2009
At a glance
- Drugs Levofloxacin (Primary)
- Indications Acute sinusitis; Bacterial infections
- Focus Therapeutic Use
- 26 May 2009 Planned number of patients changed from 530 to 784 as reported by ClinicalTrials.gov.
- 20 Nov 2005 New trial record.